172 related articles for article (PubMed ID: 14565514)
61. Long term results of surgery and chemotherapy in small cell lung cancer.
Rea F; Callegaro D; Favaretto A; Loy M; Paccagnella A; Fantoni U; Festi G; Sartori F
Eur J Cardiothorac Surg; 1998 Oct; 14(4):398-402. PubMed ID: 9845145
[TBL] [Abstract][Full Text] [Related]
62. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
63. Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study.
Livingston RB; Crowley JJ; Thompson T; Williamson SK; Meyers FJ; O'Rourke T; Neefe JR
Cancer; 1993 Jun; 71(11):3509-13. PubMed ID: 8387881
[TBL] [Abstract][Full Text] [Related]
64. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
[TBL] [Abstract][Full Text] [Related]
65. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
Edelman MJ; Chansky K; Gaspar LE; Leigh B; Weiss GR; Taylor SA; Crowley J; Livingston R; Gandara DR
J Clin Oncol; 2004 Jan; 22(1):127-32. PubMed ID: 14701775
[TBL] [Abstract][Full Text] [Related]
66. Epirubicin and ifosfamide in relapsed or refractory small cell lung cancer patients.
Jacot W; Pujol JL; Chakra M; Molinier O; Bozonnat MC; Gervais R; Quantin X
Lung Cancer; 2012 Feb; 75(2):213-6. PubMed ID: 21831476
[TBL] [Abstract][Full Text] [Related]
67. Treatment of patients with small-cell lung cancer: from meta-analyses to clinical practice.
Rossi A; Martelli O; Di Maio M
Cancer Treat Rev; 2013 Aug; 39(5):498-506. PubMed ID: 23084098
[TBL] [Abstract][Full Text] [Related]
68. [Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study].
Schütte J; Niederle N; Eberhardt W; Seeber S; Alberti W; Budach V; Hirche H; Schmidt CG
Klin Wochenschr; 1989 Dec; 67(23):1182-93. PubMed ID: 2558254
[TBL] [Abstract][Full Text] [Related]
69. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
70. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
71. Phase II and III studies with carboplatin in small cell lung cancer.
Gatzemeier U; Hossfeld DK; Neuhauss R; Reck M; Achterrath W; Lenaz L
Semin Oncol; 1992 Feb; 19(1 Suppl 2):28-36. PubMed ID: 1329220
[TBL] [Abstract][Full Text] [Related]
72. Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.
Dowlati A; Crosby L; Remick SC; Makkar V; Levitan N
Lung Cancer; 2001 May; 32(2):155-62. PubMed ID: 11325486
[TBL] [Abstract][Full Text] [Related]
73. Prospective multimodality treatment of SCLC--experience during the past 18 years.
Sun Y; Zhang XR; Yin WB; Chen DF; Zhang RG; Zhang DW
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():222-5. PubMed ID: 7661586
[TBL] [Abstract][Full Text] [Related]
74. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group.
Schiller JH; Adak S; Cella D; DeVore RF; Johnson DH
J Clin Oncol; 2001 Apr; 19(8):2114-22. PubMed ID: 11304763
[TBL] [Abstract][Full Text] [Related]
75. Radiotherapy with/without cisplatin following chemotherapy in limited small-cell lung cancer.
Scagliotti GV; Gregor A; Giaccone G
J Clin Oncol; 1998 Oct; 16(10):3479-80. PubMed ID: 9779729
[No Abstract] [Full Text] [Related]
76. Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
Reck M; Groth G; Buchholz E; Goetz E; Gatzemeier U; Manegold C
Lung Cancer; 2005 Jun; 48(3):409-13. PubMed ID: 15893010
[TBL] [Abstract][Full Text] [Related]
77. Intensive combined-modality therapy in small cell lung cancer.
Thatcher N; Lorrigan P; Burt P; Stout R
Semin Oncol; 1994 Jun; 21(3 Suppl 6):9-22. PubMed ID: 8052879
[TBL] [Abstract][Full Text] [Related]
78. Clinical trials of cyclophosphamide, etoposide, and vincristine in the treatment of small-cell lung cancer.
Comis RL
Semin Oncol; 1986 Sep; 13(3 Suppl 3):40-4. PubMed ID: 3020699
[TBL] [Abstract][Full Text] [Related]
79. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
[TBL] [Abstract][Full Text] [Related]
80. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]